"Therapeutic Polymeric Nanoparticles with mTOR Inhibitors and Methods of ... 4-traders (press release) For example, disclosed herein is a therapeutic nanoparticle comprising about 1 to about 20 weight percent of a therapeutic agent (such as for example sirolimus, temsirolimus, or everolimus) and about 50 to about 99 weight percent of a biocompatible ... |
